Louis Ricketts-Williams's Contact Details

Louis Ricketts-Williams's Company Details

GENR8 WITHIN

N/A, N/A, gb • 20 - 49 Employees
Major Drugs

Genr8 within is an evidence-based company providing next-generation treatments for orthopedic defects, chronic wounds, nerve, ligament and tendon repair. Genr8 within believes in developing transparent, long-term professional and personal relationships with physicians and our sales partners. Our goal is to deliver safe, effective, innovative solutions to improve outcomes for our number one priority, the patient.Amnion-derived products harness the human body's natural potential to regenerate tissue and return to a pre-wound state. Physicians have applied amniotic membrane products to facilitate proper healing in chronic cutaneous wounds, including diabetic, venous, arterial and decubitus ulcers with incredible success, enabling closure of even the most difficult to treat chronic wounds.Physicians and Scientists alike continue their efforts to unlock the amazing regenerative potential of the human amnion and amniotic fluid in more and more modern-day treatments. Currently, amnion-derived products have proven their value to focus the human body's natural ability to regenerate at point of injury,